New SARS-CoV-2 Variants Challenge Vaccines Protection

AIDS Rev. 2021 Feb 22;23(1):57-58. doi: 10.24875/AIDSRev.M21000040.

Authors

Vicente Soriano¹, José V Fernández-Montero²

Affiliations

¹ UNIR Health Sciences School and Medical Center, Madrid, Spain.
² Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock, Scotland, UK; University of Glasgow School of Medicine, Glasgow, Scotland, UK.

PMID: 33750742
DOI: 10.24875/AIDSRev.M21000040

No abstract available

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use
COVID-19 / prevention & control*
COVID-19 / virology*
COVID-19 Drug Treatment
COVID-19 Vaccines / immunology*
Humans
SARS-CoV-2 / drug effects
SARS-CoV-2 / genetics*

Substances

Antiviral Agents
COVID-19 Vaccines